Press Releases - Bristol Myers Squibb
Receive updated news from preferred websites, which are sent directly to the user's news reader. This includes the headlines, summaries and links to the full article on the website. Learn how
Bristol Myers Squibb - Bristol Myers Squibb Reports First Quarter ...
Apr 25, 2024 · Bristol Myers Squibb is executing a strategic productivity initiative that will drive approximately $1.5 billion in cost savings by the end of 2025, the majority of which will be …
Bristol Myers Squibb - Bristol Myers Squibb Completes Acquisition …
Mar 18, 2024 · Bristol Myers Squibb will provide an update to its financial outlook when it reports first quarter 2024 results on April 25, 2024. Advisors. Gordon Dyal & Co. and Citi are serving …
Corporate news details - Bristol Myers Squibb
Aug 21, 2024 · Bristol Myers Squibb: Creating a Better Future for People with Cancer. Bristol Myers Squibb is inspired by a single vision — transforming patients’ lives through science. The …
Bristol Myers Squibb - Bristol Myers Squibb to Participate in Citi’s ...
Nov 26, 2024 · Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in Citi’s 2024 Global Healthcare Conference. Christopher Boerner, Ph.D., board …
Bristol Myers Squibb - Bristol Myers Squibb Adds Premier ...
Dec 26, 2023 · “Acquiring RayzeBio’s differentiated actinium-based radiopharmaceutical platform will establish Bristol Myers Squibb’s presence in one of the most promising and fastest …
Bristol Myers Squibb - U.S. FDA Approves Bristol Myers Squibb’s ...
Mar 14, 2024 · U.S. FDA Approves Bristol Myers Squibb’s Breyanzi ® as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or …
Corporate news details - Bristol Myers Squibb
Oct 8, 2023 · Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value Right Acquisition …
Bristol Myers Squibb - Bristol Myers Squibb to Participate in UBS ...
Jul 8, 2024 · Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in Virtual Targeted Protein Degradation Day hosted by UBS. Robert Plenge, M.D., …
Bristol Myers Squibb - Bristol Myers Squibb Completes Acquisition …
Jan 23, 2024 · Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Mirati Therapeutics, Inc. ® (“Mirati”). With the completion of the …